Autoinhibition of c-Abl (Q40752403)

23 September 2017

title

Autoinhibition of c-Abl (English)

1 reference

23 September 2017

0 references

2

1 reference

23 September 2017

3

1 reference

23 September 2017

Helma Pluk

1

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

23 September 2017

1 reference

23 September 2017

volume

108

1 reference

23 September 2017

issue

2

1 reference

23 September 2017

page(s)

247-259

1 reference

Coordinate activation of c-Src by SH3- and SH2-binding sites on a novel p130Cas-related protein, Sin.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

An intramolecular SH3-domain interaction regulates c-Abl activity

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

A nuclear tyrosine phosphorylation circuit: c-Jun as an activator and substrate of c-Abl and JNK.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

TATA box mutations in the Schizosaccharomyces pombe nmt1 promoter affect transcription efficiency but not the transcription start point or thiamine repressibility

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Cytoskeletal protein PSTPIP1 directs the PEST-type protein tyrosine phosphatase to the c-Abl kinase to mediate Abl dephosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Regulation of human c-Abl tyrosine kinase activity in Xenopus oocytes and acceleration of progesterone-induced G2/M transition by oncogenic forms.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Oncogenic activation of c-ABL by mutation within its last exon.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Crosstalk between the catalytic and regulatory domains allows bidirectional regulation of Src.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

New-age drug meets resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Rac is required for v-Abl tyrosine kinase to activate mitogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Structures of Src-family tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Activation of c-Abl kinase activity and transformation by a chemical inducer of dimerization

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Structure-function relationships in Src family and related protein tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Cycling, stressed-out and nervous: cellular functions of c-Abl

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Regulation of cell death by the Abl tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

Inhibition of c-Abl tyrosine kinase activity by filamentous actin

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2802%2900623-2

7 January 2021

10.1016/S0092-8674(02)00623-2

Identifiers

DOI

1 reference

23 September 2017

1 reference